2017 annual financial data
Heron Therapeutics 2017 Operating margin
Direct answer
Operating margin was -632.36%.
Operating income was -194,558,000 USD and net income was -197,484,000 USD.
Operating cash flow was -170,300,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 30,767,000 USD
- Operating income
- -194,558,000 USD
- Net income
- -197,484,000 USD
- Operating cash flow
- -170,300,000 USD